← back to search

Tim Indersmitten

Vertex Pharmaceuticals (United States) · US
Area of research
Cellular and Molecular Neuroscience · Molecular Biology
Research interest
Research interests include Neuroscience and Neuropharmacology Research, Memory and Neural Mechanisms, Receptor Mechanisms and Signaling, and Cardiac electrophysiology and arrhythmias.
h-index
16
citations
1,377
works
29
NIH funding
primary concept
email

Recent publications

Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington's disease
Journal of Neurophysiology 2015cited by 148position: firstdoi
TNiK Is Required for Postsynaptic and Nuclear Signaling Pathways and Cognitive Function
Journal of Neuroscience 2012cited by 109position: middledoi
Evolution of GluN2A/B cytoplasmic domains diversified vertebrate synaptic plasticity and behavior
Nature Neuroscience 2012cited by 108position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 2 papers (2012–2012) · 2 papers (2012–2012)Maksym V. Kopanitsa · UK Dementia Research Institute2 papers (2012–2012)Thomas J. O’Dell · Allen Institute for Brain Science2 papers (2012–2012) · 2 papers (2012–2012)Jess Nithianantharajah · University of Edinburgh2 papers (2012–2012)Noboru H. Komiyama · University of Edinburgh2 papers (2012–2012)Seth G. N. Grant · University of Edinburgh2 papers (2012–2012)Tomás J. Ryan · Canadian Institute for Advanced Research1 papers (2012–2012)Carlos Cepeda · University of California, Los Angeles1 papers (2015–2015)Michael S. Levine · Intel (United States)1 papers (2015–2015) · 1 papers (2012–2012)Marcelo P. Coba · University of Southern California1 papers (2012–2012)Conny Tran · University of California, Los Angeles1 papers (2015–2015)Nathan Skene · UK Dementia Research Institute1 papers (2012–2012)Kathryn A. Elsegood · University of Edinburgh1 papers (2012–2012) · 1 papers (2012–2012)David Fricker · University of Edinburgh1 papers (2012–2012) · 1 papers (2012–2012)